Neurocrine

Developer of small molecule therapeutics for endocrine and CNS disorders

placeSan Diego, California, United States calendar_todayFounded 1992 groups1,400 employees language neurocrine.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 10 times.

Social engagement

Social engagement: 101.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital571%
Private equity114%
Other / undisclosed114%

Recent activity

2 Jul 2026
Product launch
EnterpriseCAHTM
25 Jun 2026
Event
Haarington's Disease Society of America 41st Annual Convention
Coming soon